The Effect of Far-Infrared Therapy on the Peritoneal Expression of Glucose Degradation Products in Diabetic Patients on Peritoneal Dialysis

被引：0
|
作者：
Lin, Chih-Ching [1 ]
Niu, Chih-Yuan [1 ]
机构：
[1] Taipei Vet Gen Hosp, Taipei, Taiwan
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PO0986
引用
收藏
页码：333 / 333
页数：1
相关论文
共 50 条
  • [31] Proteomic analysis of peritoneal fluid of patients treated by peritoneal dialysis: effect of glucose concentration
    Cuccurullo, Manuela
    Evangelista, Ciriana
    Vilasi, Annalisa
    Simeoni, Mariadelina
    Avella, Ferdinando
    Riccio, Eleonora
    Memoli, Bruno
    Malorni, Antonio
    Capasso, Giovambattista
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (06) : 1990 - 1999
  • [32] Peritoneal glucose absorption and body fat in peritoneal dialysis patients
    Vasselai, Priscila
    Kamimura, Maria A.
    Bazanelli, Ana Paula
    Silva, Camila B.
    Avesani, Carla M.
    Sanches, Fabiana M. R.
    Manfredi, Silvia R.
    Draibe, Sergio A.
    Cuppari, Lilian
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 306 - 306
  • [33] Effect of glucose concentration on peritoneal inflammatory cytokines in continuous ambulatory peritoneal dialysis patients
    Sayarlioglu, H
    Topal, C
    Sayarlioglu, M
    Dulger, H
    Dogan, E
    Erkoc, R
    MEDIATORS OF INFLAMMATION, 2004, 13 (02) : 119 - 121
  • [34] Peritoneal dialysis prescriptions for diabetic patients
    Diaz-Buxo, JA
    ADVANCES IN PERITONEAL DIALYSIS/1999, VOL 15, 1999, 15 : 91 - 95
  • [35] Peritoneal dialysis in patients with diabetic nephropathy
    Auinger, M
    Edlinger, R
    Prager, R
    WIENER KLINISCHE WOCHENSCHRIFT, 2005, 117 : 29 - 34
  • [36] Peritoneal dialysis using icodextrin improves glucose control in diabetic patients
    Cearing, Deborah
    McGreevey, Rona
    NEPHROLOGY NURSING JOURNAL, 2006, 33 (02) : 136 - 136
  • [37] Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: Role of acidity, buffer choice, glucose concentration, and glucose degradation products
    Mortier, S
    De Vriese, AS
    Van de Voorde, J
    Schaub, TP
    Passlick-Deetjen, J
    Lameire, NH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (02): : 480 - 489
  • [38] Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells
    Witowski, J
    Korybalska, K
    Ksiazek, K
    Wisniewska-Elnur, J
    Jörres, A
    Lage, C
    Schaub, TP
    Passlick-Deetjen, J
    Breborowicz, A
    Grzegorzewska, A
    Ksiazek, A
    Liberek, T
    Lichodziejewska-Niemierko, M
    Majdan, M
    Rutkowski, B
    Stompór, T
    Sulowicz, W
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (04) : 917 - 924
  • [39] Effects of neutral pH and reduced glucose degradation products in a new peritoneal dialysis solution on morphology of peritoneal membrane in rats
    Ikehara, O
    Nishimura, H
    Naito, T
    Higuchi, C
    Sanaka, T
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2005, 100 (01): : E30 - E39
  • [40] Glucose degradation products and peritoneal membrane function
    Witowski, J
    Bender, TO
    Gahl, GM
    Frei, U
    Jörres, A
    PERITONEAL DIALYSIS INTERNATIONAL, 2001, 21 (02): : 201 - 205
12345